Recombinant human erythropoietin modulates erythrocyte complement receptor 1 functional activity in patients with lupus nephritis

Clinical Nephrology

Volumn 49, Issue 6, 1998, Pages 364-369

  Kiss, E ^a   Kavai M ^a   Csipo I ^a   Szegedi, G ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Complement receptor; Erythropoietin; Immune complex; Nephritis; SLE

Indexed keywords

BOVINE SERUM ALBUMIN; COMPLEMENT; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; CREATININE; DNA ANTIBODY; HEMOGLOBIN; IODINE 125; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOMODULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR BINDING; RETICULOCYTE;

ADOLESCENT; ADULT; ANEMIA; ANTIGEN-ANTIBODY COMPLEX; ERYTHROCYTE COUNT; ERYTHROCYTES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; LUPUS NEPHRITIS; RECEPTORS, COMPLEMENT 3B; RETICULOCYTE COUNT;

EID: 0031812964     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bannister KM, Hay J, Clarkson AR, Woodroffe AJ 1984 Fc-specific reticulo-endothelial clearance in systemic lupus erythematosus and glomerulonephritis. Am J Kidney Dis 3: 287-292
2. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on Prognosis Studies in SLE 1992 Derivation of SLE DAI. A disease activity index for lupus patients. Arthritis Rheum 35: 630-640
3. Casadevall N 1995 Cellular mechanism of resistance to erythropoietin. Nephrol Dial Transplant 10 (Suppl 6P): 27-30
4. Cofan F, Bonal J, Castellote E, Carpals A 1993 Vasculitis in haemodialysis. A new form of resistance to erythropoietin. Nephrol Dial Transplant 8: 569-570
5. Cohen JHM, Caudwell V, Levi-Strauss M 1989 Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum 32: 393-397
6. Cornacoff JB, Heben LA, Smead WL, Van Aman ME, Birmingham DH, Waxman FJ 1983 Primate erythrocyte-immune complex-clearing mechanisms. J Clin Invest 71: 236-247
7. Eschbach JW, Egril JC, Downing MR, Browning MR, Brown JK, Adamson JW 1987 Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. New Engl J Med 316: 73-78
8. Eschbach JW, Adamson JW 1988 Recombinant human erythropoietin: Implications for nephrology. Am J Kidney Dis 9: 203-209
9. Faquin WC, Schneider TJ, Goldberg MA 1992 Regulation of erythropoietin production by inflammatory cytokines. Possible role in the pathogenesis of anaemia of chronic disease. Blood 79: 1987-1994
10. Hebert LA, Birmingham DJ, Shen X-P, Cosio FG 1992 Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clin Immunol Immunopathol 62: 301-306
11. Hebert LA, Birmingham DJ, Shen XP, Brandt JT, Sedmak DD, Dillon JJ 1994 Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Am J Kidney Dis 24: 25-32
12. Holme E. Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K 1986 Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 63: 41-48
13. Iida K, Mornaghi R, Nussenzweig V 1982 Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 155: 1427-1438
14. Jepsen HH, Svehag S-E, Jarlbaek L, Baatrup G 1986 Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction. Scand J Immunol 23: 65-73
15. Jepsen HH, Rasmussen JM, Teisner B, Schröder L, Hamolskow U, Jarlbaek L, Isager H, Svehag SE 1990 Immune complex binding to erythrocyte CR1 (CD35), CR1 expression and levels of erythrocyte-fixed C3 fragments in systemic lupus erythematosus outpatients. APMIS 98: 637-644
16. Kavai M, Banyai Z, Zsindely A, Sonkoly I, Szegedi GY 1982 An enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus. J Immunol Methods 48: 169-175
17. Kiss E, Csipõ I, Cohen JHM, Reveil B, Kávai M, Szegedi G 1996 CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Autoimmunity 25: 53-58
18. Koffler D, Agnello V, Throburn R, Kunkel HG 1971 Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 134: 169-179
19. Kontessis PS, Paraskevopoulos A, Papageorgiu I, Rappini P, Digenis DF, Antsaklis A, Zefros N 1995 Successful use of recombinant human erythropoietin in a pregnant woman with lupus nephritis. Am J Kidney Dis 26: 781-784
20. Madi N, Paccaud JP, Steiger G, Schifferli JA 1991 Immune complex binding efficacy of erythrocytes with different CR1 numbers or alleles. Clin Exp Immunol 84: 9-15
21. Moldenhauer F, David J, Fielder AHL, Lachmann PJ, Walport MJ 1987 Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum 30: 961-966
22. Moldenhauer F, Botto M, Walport MJ 1988 The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin Exp Immunol 72: 74-78
23. Parris TM, Kimberley RP, Inman RD, Mc Dougal JS, Gibovsky A, Christian CL 1982 Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med 97: 526-532
24. Peeters HRM, Jongen-Lavrencic M, Vrengdenhil G, Swaak AJC 1996 Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis 55: 739-744
25. Pincus T, Olsen NJ, Russel J, Wolfe F, Harris ER, Schwitzler TJ 1990 Multicenter study of recombinant human erythropoietin in correction of anaemia in rheumatoid arthritis. Am J Med 89: 161-168
26. Ross GD, Medof ME 1985 Membrane complement receptors specific for bound fragments of C3. Adv Immunol 37: 217-267
27. Salvarini C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F 1991 Recombinant human erythropoietin therapy in patients with rheumatoid arthritis and with anaemia of chronic disease. J Rheumatol 18: 1168-1171
28. Schifferli JA, Ng YC, Peters DK 1986 The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315: 488-495
29. Schifferli JA, Ng YC, Estreich J, Walport MJ 1989 The role of hypocomplementaemia and low erythrocyte complement receptor 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol 35: 993-1003
30. Takashina N, Kondo H, Kashiwazaki S 1990 Suppressed serum erythropoietin respons to anaemia and the efficacy of recombinant erythropoietin in anaemia of rheumatoid arthritis. J Rheumatol 17: 885-887
31. Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NC, Schaller JG, Talal N, Winchester RJ 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277
32. Toylor RP, Horgan C, Buschbacher R, Bruhher CM, Hess CE, O'Brien KM, Wanevo HJ 1983 Decreased complement mediated binding of antibody, 3H-dsDNA immune complexes to red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum 26: 736-744
33. Walport MJ, Ross GD, Macworth-Young CG, Watson JG, Hogg N, Lachmann PJ 1985 Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are aquired, not inherited. Clin Exp Immunol 59: 547-554
34. Wilson JG, Wong WW, Schur P, Fearon DT 1981 Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 307: 981-986
35. Wilson JG, Wong WW, Murphy EE, Schur P, Fearon DT 1987 Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: Analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J Immunol 138: 2706-2710
36. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM 1986 Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2: 1175-1178